Skip to main content
. Author manuscript; available in PMC: 2013 Feb 20.
Published in final edited form as: Mol Psychiatry. 2012 Apr 3;18(2):138–140. doi: 10.1038/mp.2012.28

Table 1.

Summary of Stage 3 replication genotyping results.

Gene Single-marker analysis (57 SNVs) Gene-based analysis (35 SNVs)
# SNVs EUR (minimum p-value) AFR (minimum p-value) # uncommon variants EUR (# of case/control alternative allele) EUR p-values (CALPHA/VT) AFR (# of case/control alternative allele) AFR p-values (CALPHA/VT)
COMT 4 0.037 0.128 3 8/1 0.02/0.003 0/3 0.29/0.71
DAOA 5 0.039 0.121 0 - - - -
DISC1 22 0.099 0.081 20 32/40 0.67/0.33 39/32 0.27/0.08
DRD3 3 0.375 0.264 0 - - - -
DTNBP1 5 0.390 0.106 5 18/19 0.32/0.72 7/4 0.34/0.16
HTR2A 3 0.037 0.380 1 3/13 0.03/0.7 0/1 0.71/0.71
NRG1 8 0.119 0.017 1 4/1 0.14/0.1 159/185 0.34/0.15
SLC6A3 4 0.339 0.326 2 4/4 0.6/0.8 0/1 0.76/0.67
SLC6A4 3 0.418 0.310 3 10/9 0.45/0.25 1/1 0.4/0.36

Single-marker and aggregate analyses of EUR and AFR samples. Logistic regression was performed on 57 SNVs. Gene-based analysis was performed on 35 exonic SNVs.